Aptevo Therapeutics Inc.

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP
03835L207
SEDOL
N/A
CIK
0001671584
www.aptevotherapeutics.com
LEI:
©
FIGI: -
APVO
Aptevo Therapeutics Inc.
GICS: - · Sector: Healthcare · Sub-Sector: Biotechnology
NAME
Aptevo Therapeutics Inc.
ISIN
US03835L2079
TICKER
APVO
MIC
XNAS
REUTERS
APVO.OQ
BLOOMBERG
APVO US
BUILD THEMEFOLIO SHARE IDEAS DISCUSS
LEVERAGE INVEST
EN 728x90
Financial Intelligence
360° iHub Crowd iFeed ATH Tracker Index Tracker ETF TF Spicy2 X-Billboard
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants

The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by AccessWire.

Wed, 18.09.2024       Aptevo Therapeutics
US03835L2079

SEATTLE, WA / ACCESSWIRE / September 18, 2024 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced the closing of its previously announced offering of (i) 9,090,9...
Read More
Aptevo Therapeutics
Technical Analysis Termsheet Terminal
Permalink
Mon, 16.09.2024       Aptevo Therapeutics
US03835L2079

SEATTLE, WA / ACCESSWIRE / September 16, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced that it has entered into securities purchase agreements with ce...
Read More
Aptevo Therapeutics
Technical Analysis Termsheet Terminal
Permalink
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements